Jonathan Sims is a Senior Director at Eli Lilly and Company, having held this position since 2022 after serving as a Director. Previously, Sims worked as a Principal Research Scientist, focusing on significant research contributions related to atopic dermatitis and COVID-19. They earned a Ph.D. in Molecular & Biomedical Pharmacology from the University of Kentucky and a B.S. in Recombinant Genetics and Chemistry from Western Kentucky University. Sims' research has been published in several reputable journals, showcasing a commitment to advancing medical science.
Location
Indianapolis, United States
This person is not in the org chart
This person is not in any teams
This person is not in any offices